Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
A new study suggests increasingly popular GLP-1 drugs could help cut opioid and alcohol abuse nearly in half.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
Not long after pledging to operate a digital bank in America, Spain’s most valuable lender is reevaluating its business in the UK.
The EU wants everyone to know it has no intention of genuflecting toward a new Trump administration and won’t stop doling out Big Tech fines.
After a brief blackout period from late Saturday, TikTok began restoring services to US users on Sunday morning.